August 26, 2016 4:35 AM ET

Company Overview of Poliwogg Regenerative Medicine Fund, Inc.

Executive Profile

Samuel P. Wertheimer Ph.D.

Executive Vice President, Chairman of the Board of Directors and Member of Valuation Committee, Poliwogg Regenerative Medicine Fund, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 5 different industries.

See Board Relationships
----

Background

Dr. Samuel P. Wertheimer, also known as Sam, Ph.D. serves as Director at Cerimon Pharmaceuticals, Inc. Dr. Wertheimer serves as Executive Vice President, Chairman of the Board of Directors and Member of Valuation Committee at Poliwogg Regenerative Medicine Fund, Inc. Dr. Wertheimer has a Ph.D. in Molecular Biology from New York University, an M.P.H from Yale University, and a B.A. from the Johns Hopkins University.

Corporate Headquarters

733 Third Avenue
New York, New York 10017

United States

Phone: 212-986-7900
Fax: --

Board Members Memberships

Director
Executive Vice President, Chairman of the Board of Directors and Member of Valuation Committee

Education

Unknown/Other Education
Yale University
PhD
New York University
BA
Johns Hopkins University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Poliwogg Regenerative Medicine Fund, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.